Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.57
- Piotroski Score 6.00
- Grade Outperform
- Symbol (SNN)
- Company Smith & Nephew plc
- Price $25.32
- Changes Percentage (1.12%)
- Change $0.28
- Day Low $25.08
- Day High $25.37
- Year High $31.72
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
- Last Earnings 07/01/2024
- Ex-Dividend for 5/16 Dividend 10/04/2024
- Dividend Payable 11/08/2024
- Today N/A
- Next Earnings (Estimated) 02/25/2025
- Fiscal Year End N/A
- Average Stock Price Target $27.00
- High Stock Price Target $27.00
- Low Stock Price Target $27.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.60
- Trailing P/E Ratio 43.9
- Forward P/E Ratio 43.9
- P/E Growth 43.9
- Net Income $263.00 M
Income Statement
Quarterly
Annual
Latest News of SNN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Societatea Nationala Nuclearelectrica SA (BSE:SNN) Q3 2024 Earnings Call Highlights: Navigating ...
The recent court decision on windfall taxation is uncertain, potential impact could be beneficial depending on regulatory enforcement. Sales mix changes were influenced by regulations, shifting toward...
By Yahoo! Finance | 1 week ago -
Earnings Beat: Smith & Nephew plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Smith & Nephew plc (LON:SN.) saw a 5.7% rise in shares post-release of its interim results. Analysts predict a revenue increase to US$5.81b in 2024, with a 46% leap in EPS....
By Yahoo! Finance | 3 months ago -
Smith & Nephew plc (SNN): One of the Best FTSE Dividend Stocks to Buy Now?
A review of the top FTSE dividend stocks includes Smith & Nephew plc (NYSE:SNN), known for its impressive dividend yield. Despite its recent stock decline, the company's strong outlook for fiscal 2024...
By Yahoo! Finance | 4 months ago
